ANI Pharmaceuticals (ANIP)

[big bambino]

I'm not as knowledgeable as most on this board,but I have a simple question. A lot is being said about the patent for Libigel has been abandoned as it's initial intentions for HSDD. Now anyone can come and apply a patent for the same product (maybe not the same composition) and go thru an arduous trial period of say a few years, correct. Now Anip and their associates have all the data of the separate findings for CV events & breast cancer reduction, which they would not need numerous years of trials to obtain (since they already posses the data). Now why would they be worried about letting Libigel ( which already has thousands of off script prescriptions filled yearly anyway) patent expire, when they have 2 potential blockbuster products in their hip pocket, so to speak. Libigel efficacy failed, so let that go. Now let's go after the other 2 bigger fish in the pond, that we have a line already into, just needing to reel them in. Does that seem reasonable or just a rambling?